Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Amenta

Showing results (91-100 of 214) with videos related to

Pageof 22
Sort By:
Acta Bio-Medica : Atenei Parmensis|October 4, 2019
First surveillance of malaria among seafarers: evaluation of incidence and identification of risk areasGraziano Pallotta, Marzio Di Canio, Stefania Scuri, et al.
International Maritime Health|March 29, 2014
Psychological distress in families of victims of maritime piracy - the Italian experienceAntonio Rosario Ziello, Rolando Degli Angioli, Angiola Maria Fasanaro, et al.
International Maritime Health|October 1, 2020
Coronavirus variant COVID-19 pandemic: a report to seafarersPaolo Sossai, Silvia Uguccioni, Giuseppe Sandro Mela, et al.
Frontiers in Medicine|August 29, 2022
Role of teledermatology in the management of dermatological diseases among marine workers: A cross-sectional study comparing general practitioners and dermatological diagnosesMarzio Di Canio, Lorenza Burzi, Simone Ribero, et al.
Cells|October 23, 2021
Altered Brain Cholinergic and Synaptic Markers in Obese Zucker RatsIlenia Martinelli, Daniele Tomassoni, Proshanta Roy, et al.
Journal of the Neurological Sciences|September 11, 2012
The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim resultsFrancesco Amenta, Anna Carotenuto, Angiola Maria Fasanaro, et al.
Journal of Alzheimer'S Disease : JAD|June 6, 2014
The ASCOMALVA (Association between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in Alzheimer's Disease) Trial: interim results after two years of treatmentFrancesco Amenta, Anna Carotenuto, Angiola Maria Fasanaro, et al.
Nutrients|August 10, 2024
Correction: Tayebati et al. Choline and <i>Choline alphoscerate</i> Do Not Modulate Inflammatory Processes in the Rat Brain. <i>Nutrients</i> 2017, <i>9</i>, 1084Seyed Khosrow Tayebati, Ilenia Martinelli, Michele Moruzzi, et al.
Journal of the Neurological Sciences|March 24, 2009
Neuroprotective effect of treatment with galantamine and choline alphoscerate on brain microanatomy in spontaneously hypertensive ratsSeyed Khosrow Tayebati, Maria Antonietta Di Tullio, Daniele Tomassoni, et al.
Mechanisms of Ageing and Development|November 22, 2005
Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: an approach for enhancing cholinergic neurotransmissionFrancesco Amenta, Seyed Khosrow Tayebati, Daniela Vitali, et al.
Pageof 22

Showing results (91-100 of 214) with videos related to

Sort By:
Pageof 22
Acta Bio-Medica : Atenei Parmensis|October 4, 2019
First surveillance of malaria among seafarers: evaluation of incidence and identification of risk areasGraziano Pallotta, Marzio Di Canio, Stefania Scuri, et al.
International Maritime Health|March 29, 2014
Psychological distress in families of victims of maritime piracy - the Italian experienceAntonio Rosario Ziello, Rolando Degli Angioli, Angiola Maria Fasanaro, et al.
International Maritime Health|October 1, 2020
Coronavirus variant COVID-19 pandemic: a report to seafarersPaolo Sossai, Silvia Uguccioni, Giuseppe Sandro Mela, et al.
Frontiers in Medicine|August 29, 2022
Role of teledermatology in the management of dermatological diseases among marine workers: A cross-sectional study comparing general practitioners and dermatological diagnosesMarzio Di Canio, Lorenza Burzi, Simone Ribero, et al.
Cells|October 23, 2021
Altered Brain Cholinergic and Synaptic Markers in Obese Zucker RatsIlenia Martinelli, Daniele Tomassoni, Proshanta Roy, et al.
Journal of the Neurological Sciences|September 11, 2012
The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim resultsFrancesco Amenta, Anna Carotenuto, Angiola Maria Fasanaro, et al.
Journal of Alzheimer'S Disease : JAD|June 6, 2014
The ASCOMALVA (Association between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in Alzheimer's Disease) Trial: interim results after two years of treatmentFrancesco Amenta, Anna Carotenuto, Angiola Maria Fasanaro, et al.
Nutrients|August 10, 2024
Correction: Tayebati et al. Choline and <i>Choline alphoscerate</i> Do Not Modulate Inflammatory Processes in the Rat Brain. <i>Nutrients</i> 2017, <i>9</i>, 1084Seyed Khosrow Tayebati, Ilenia Martinelli, Michele Moruzzi, et al.
Journal of the Neurological Sciences|March 24, 2009
Neuroprotective effect of treatment with galantamine and choline alphoscerate on brain microanatomy in spontaneously hypertensive ratsSeyed Khosrow Tayebati, Maria Antonietta Di Tullio, Daniele Tomassoni, et al.
Mechanisms of Ageing and Development|November 22, 2005
Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: an approach for enhancing cholinergic neurotransmissionFrancesco Amenta, Seyed Khosrow Tayebati, Daniela Vitali, et al.
Pageof 22